Details of the Drug Reposition

General Information of This Drug (ID: DMTHZ2V)

Drug Name	RNS60 DMTHZ2V

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Multiple sclerosis	DISB2WZI	8A40	Phase 2	[1]
Amyotrophic lateral sclerosis	DISF7HVM	8B60.0	Phase 2	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT01714089) Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple Sclerosis. U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT03456882) The Effect of RNS60 on ALS Biomarkers (RNS60). U.S. National Institutes of Health.